Better Peptides via Chemical Glycosylation: Somatostatin Analogues Having a Human Complex‐Type N‐Glycan with Improved Drug Properties
- 21 April 2023
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 29 (31) , e202300111
Abstract
Somatostatin (somatotropin release‐inhibiting factor, SRIF) is a growth hormone inhibitory factor in the form of a 14‐ or 28‐amino acid peptide. SRIF affects several physiological functions through its action on five distinct SRIF receptor subtypes (sst1–5). Native SRIF has only limited clinical applications due to its rapid degradation in plasma. To overcome this obstacle, we have developed glycosylated SRIF analogues that possess not only metabolic stability but also high affinity to all five receptor subtypes by attaching human complex‐type oligosaccharides. Such glycosylated SRIF analogues with improved pharmacokinetic profiles could be potent and novel therapeutic drugs for SRIF‐related diseases in which several SRIF receptor subtypes are closely involved, and also shed light on new indications. Our results show that chemical glycosylation can be a powerful tool for the development of peptide and protein analogues superior to the original molecules with enhanced drug properties.Keywords
This publication has 46 references indexed in Scilit:
- 4-Methoxybenzyloxymethyl Group, a Racemization-Resistant Protecting Group for Cysteine in Fmoc Solid Phase Peptide SynthesisOrganic Letters, 2012
- Biochemical Assessment of Erythropoietin Products From Asia Versus US Epoetin alfa Manufactured by AmgenJournal of Pharmaceutical Sciences, 2009
- Recent progress in the field of glycopeptide synthesisPeptide Science, 2007
- Advances in glycoprotein synthesisChemical Communications, 2005
- Roles of N-Linked Glycans in the Endoplasmic ReticulumAnnual Review of Biochemistry, 2004
- Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability,Biochemistry, 2003
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- The Synthesis of Cystine Peptides by Iodine Oxidation of S‐Trityl‐cysteine and S‐Acetamidomethyl‐cysteine PeptidesHelvetica Chimica Acta, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973